Profile data is unavailable for this security.
About the company
INSPECS Group plc is a United Kingdom-based provider of eyewear solutions for the global eyewear market. The Company produces a range of eyewear frames, low vision aids and lenses, covering optical, sunglasses and safety, which are either under license or under the Company’s own proprietary brands (Branded), or unbranded or private label on behalf of retail customers (OEM). The Company’s segments include Frames and Optics, which is involved in product distribution; Wholesale, which is engaged in OEM and manufacturing distribution, and Lenses which is engaged in manufacturing and distribution of lenses. The Company has operations in the United Kingdom, Germany, Portugal, Scandinavia, the United States and China (including Hong Kong, Macau and Shenzhen). Its customers are global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 75,000 points of sale.
- Revenue in GBP (TTM)203.29m
- Net income in GBP-997.00k
- Incorporated2019
- Employees1.67k
- LocationInspecs Group PLC7-10 Kelso PlaceBATH United KingdomGBR
- Websitehttps://inspecs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modulight Oyj | -84.91bn | -84.91bn | 47.76m | 70.00 | -- | 1.04 | -- | -- | -- | -- | -- | 1.26 | -- | -- | -- | -- | -- | -8.39 | -- | -9.10 | -- | 114.69 | -- | -56.81 | 6.11 | -- | 0.1004 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Affluent Medical SAS | 0.00 | -13.29m | 51.50m | 52.00 | -- | -- | -- | -- | -0.5828 | -0.5828 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.85 | -- | -- | -- | -- | -2.80 | -- | -- | -- |
| Mentice AB | 18.94m | -1.94m | 52.05m | 128.00 | -- | 5.15 | 1,702.51 | 2.75 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Senzime AB (publ) | 3.03m | -9.79m | 52.12m | 52.00 | -- | 2.36 | -- | 17.22 | -1.30 | -1.30 | 0.3902 | 2.95 | 0.1045 | 1.34 | 5.80 | -- | -33.80 | -35.69 | -35.58 | -38.00 | 26.75 | -20.59 | -323.45 | -558.68 | 5.85 | -- | 0.0308 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Medicalgorithmics SA | 7.64m | -1.20m | 52.66m | 120.00 | -- | 3.02 | -- | 6.89 | -0.6131 | -0.6131 | 3.90 | 8.91 | 0.3263 | 4.13 | 9.12 | 323,541.70 | -5.13 | -0.9441 | -5.91 | -1.18 | -7.04 | 2.59 | -15.72 | -2.19 | 2.22 | -10.16 | 0.0451 | 0.00 | -31.28 | -26.39 | -102.27 | -- | -18.81 | -- |
| Paxman AB (publ) | 16.88m | 1.79m | 67.20m | 94.00 | 37.67 | 6.62 | 21.17 | 3.98 | 1.26 | 1.26 | 11.89 | 7.16 | 1.28 | 2.66 | 6.46 | 2,488,099.00 | 13.59 | -5.08 | 18.38 | -7.76 | 69.47 | 69.38 | 10.59 | -5.07 | 1.76 | -- | 0.1122 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Integrum AB | 7.17m | 615.76k | 70.33m | 34.00 | 118.56 | 6.63 | 90.97 | 9.80 | 0.447 | 0.447 | 5.19 | 7.99 | 0.5918 | 0.5859 | 3.83 | -- | 5.08 | -6.65 | 5.65 | -7.95 | 86.80 | 81.52 | 8.58 | -11.19 | 3.04 | -4.28 | 0.0462 | -- | 33.29 | 37.39 | -117.50 | -- | 86.42 | -- |
| OssDsign AB | 8.78m | -8.83m | 72.09m | -- | -- | 4.31 | -- | 8.21 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | -- | -39.29 | -38.80 | -43.39 | -44.72 | 77.15 | 72.29 | -100.57 | -203.05 | 5.18 | -36.90 | 0.013 | -- | 96.82 | 53.26 | -31.30 | -- | -60.35 | -- |
| SDI Group PLC | 68.07m | 1.61m | 73.19m | 489.00 | 46.11 | 1.68 | 12.40 | 1.08 | 0.0152 | 0.0152 | 0.6528 | 0.4174 | 0.7958 | 2.08 | 6.29 | 139,206.50 | 1.93 | 8.83 | 2.34 | 11.43 | 63.34 | 64.57 | 2.43 | 10.64 | 1.14 | 5.86 | 0.3311 | 0.00 | 36.09 | 36.05 | -48.68 | 19.11 | 11.86 | -- |
| Inspecs Group PLC | 203.29m | -997.00k | 74.22m | 1.67k | -- | 0.717 | 6.16 | 0.3651 | -0.0109 | -0.0109 | 1.94 | 1.02 | 0.8864 | 2.24 | 8.68 | 121,513.40 | -0.4347 | -1.48 | -0.6975 | -2.15 | 50.94 | 48.50 | -0.4904 | -1.97 | 0.8677 | 1.54 | 0.375 | -- | 1.16 | 36.45 | 84.22 | -- | 51.04 | -- |
| Oncosem Onkolojik Sistemlr Sny v Tcrt AS | 5.85m | -1.94m | 82.08m | 324.00 | -- | 14.57 | -- | 14.03 | -3.44 | -3.44 | 10.15 | 9.72 | 0.6993 | 2.47 | 3.93 | 742,302.40 | -23.20 | -- | -31.86 | -- | 14.88 | -- | -33.18 | -- | 1.30 | -- | 0.2087 | -- | -17.90 | -- | -284.37 | -- | -- | -- |
| Carmat SA | 2.37m | -45.74m | 90.41m | 182.00 | -- | -- | -- | 38.07 | -2.18 | -2.18 | 0.1128 | -1.09 | 0.0405 | 1.63 | 0.6353 | 15,368.13 | -77.90 | -76.92 | -97.48 | -94.38 | -1,109.12 | -- | -1,925.92 | -4,636.64 | 1.19 | -17.09 | 1.88 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
| Meditera Tibbi Mlzm Sny Tcrt AS | 35.32m | 629.09k | 92.61m | 728.00 | 147.22 | 2.55 | 47.92 | 2.62 | 0.2174 | 0.2174 | 12.20 | 12.53 | 0.7678 | 2.92 | 5.31 | 1,994,873.00 | 1.37 | 9.37 | 1.59 | 11.54 | 44.33 | 43.51 | 1.78 | 9.85 | 2.83 | -- | 0.0552 | 181.79 | -8.99 | 48.75 | -77.38 | 15.68 | -- | -- |
| Mercator Medical SA | 92.32m | -3.87m | 94.83m | 961.00 | -- | 0.5128 | -- | 1.03 | -1.03 | -1.03 | 56.73 | 88.23 | 0.458 | 2.63 | 7.06 | 488,099.90 | -2.23 | 24.69 | -2.39 | 29.07 | 2.41 | 36.99 | -4.87 | 22.78 | 5.57 | -- | 0.0063 | -- | -13.54 | 2.21 | 89.62 | -- | -1.93 | -- |
| Optomed Oyj | 12.69m | -3.71m | 99.29m | 114.00 | -- | 5.96 | -- | 7.82 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
Data as of Jun 07 2024. Currency figures normalised to Inspecs Group PLC's reporting currency: UK Pound GBX
56.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Canaccord Genuity Wealth Ltd.as of 17 Apr 2024 | 18.82m | 18.52% |
| Downing LLPas of 19 Apr 2024 | 7.39m | 7.27% |
| Liontrust Investment Partners LLPas of 31 Dec 2022 | 5.69m | 5.60% |
| Amati Global Investors Ltd.as of 31 Dec 2022 | 5.69m | 5.60% |
| Hargreaves Lansdown Fund Managers Ltd.as of 31 Dec 2022 | 4.78m | 4.70% |
| Royal London Asset Management Ltd.as of 31 Dec 2022 | 3.97m | 3.90% |
| Invesco Asset Management Ltd.as of 31 Dec 2022 | 3.76m | 3.70% |
| Stonehage Fleming SAas of 31 Dec 2022 | 3.15m | 3.10% |
| Ninety One UK Ltd.as of 29 Feb 2024 | 2.42m | 2.38% |
| Threadneedle Asset Management Ltd.as of 29 Feb 2024 | 2.16m | 2.12% |
More ▼
Data from 31 Dec 2022 - 31 May 2024Source: FactSet Research Systems Inc.
